• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    BioAge Labs, Inc. - Common Stock (NQ:BIOA)

    4.120 -0.280 (-6.36%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 324,137
    Open 4.360
    Bid (Size) 4.120 (2)
    Ask (Size) 4.700 (1)
    Prev. Close 4.400
    Today's Range 4.110 - 4.430
    52wk Range 2.880 - 26.62
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
    From BioAge Labs, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -25.9%
    -25.9%
    1 Month
    -2.8%
    -2.8%
    3 Month
    -1.7%
    -1.7%
    6 Month
    -10.2%
    -10.2%
    1 Year
    -77.5%
    -77.5%

    More News

    Read More
    BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
    From BioAge Labs, Inc.
    Via GlobeNewswire
    BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
    From BioAge Labs, Inc.
    Via GlobeNewswire
    BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
    From BioAge Labs, Inc.
    Via GlobeNewswire
    BioAge Labs to Present at Upcoming Investor Conferences
    From BioAge Labs, Inc.
    Via GlobeNewswire
    BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
    From BioAge Labs, Inc.
    Via GlobeNewswire
    Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates
    From Grabar Law Office
    Via GlobeNewswire
    Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates
    From Grabar Law Office
    Via GlobeNewswire
    Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)
    From Grabar Law Office
    Via GlobeNewswire
    BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
    From BioAge Labs, Inc.
    Via GlobeNewswire
    BIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action – BIOA
    From The Rosen Law Firm PA
    Via GlobeNewswire
    BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Final BIOA Deadline Reminder: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
    Via TheNewswire.com
    Topics Initial Public Offering Lawsuit
    Final BIOA Deadline Reminder: March 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
    Via NewMediaWire
    Topics Initial Public Offering Lawsuit
    BIOA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit
    Via NewMediaWire
    Topics Initial Public Offering Lawsuit
    BIOA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit
    Via TheNewswire.com
    Topics Initial Public Offering Lawsuit
    Deadline Soon: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    BIOA Deadline: Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    BIOA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit
    Via NewMediaWire
    Topics Initial Public Offering Lawsuit
    BIOA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit
    Via TheNewswire.com
    Topics Initial Public Offering Lawsuit
    BIOA DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action – BIOA
    From The Rosen Law Firm PA
    Via GlobeNewswire
    BIOA Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit
    Via NewMediaWire
    Topics Initial Public Offering Lawsuit

    Frequently Asked Questions

    Is BioAge Labs, Inc. - Common Stock publicly traded?
    Yes, BioAge Labs, Inc. - Common Stock is publicly traded.
    What exchange does BioAge Labs, Inc. - Common Stock trade on?
    BioAge Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for BioAge Labs, Inc. - Common Stock?
    The ticker symbol for BioAge Labs, Inc. - Common Stock is BIOA on the Nasdaq Stock Market
    What is the current price of BioAge Labs, Inc. - Common Stock?
    The current price of BioAge Labs, Inc. - Common Stock is 4.120
    When was BioAge Labs, Inc. - Common Stock last traded?
    The last trade of BioAge Labs, Inc. - Common Stock was at 08/01/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.